Welcome to Insider Healthcare. I’m healthcare editor Leah Rosenbaum, and today in healthcare news:
- A top biotech VC shares what she looks for when investing in new companies;
- How two women convinced a group of millennial men to invest in a menopause symptom startup;
- A new study further proves the effectiveness of COVID-19 vaccines.
A top biotech VC looks for 2 factors when investing in startups that could shake up the healthcare industry
- Arch Venture is one of biotech’s biggest investors, leading $US200 ($AU272) million to $US800 ($AU1,088) million rounds.
- The fund’s leaders pick healthcare issues that make them angry, then look for a solution.
- Managing Director Kristina Burow wants to overhaul brain-disorder treatments and autoimmune issues.
Here is the 23-slide presentation a former Marie Claire editor-in-chief used to get millennial men to invest in a startup that treats menopause symptoms
- Alloy is a digital-health startup that treats menopause symptoms.
- Kairos HQ and PACE Healthcare Capital participated in its $US3.3 ($AU4) million seed round on Wednesday.
- Alloy is planning to launch a mail-order estrogen product in November.
Vaccines cut the risk of severe COVID-19 by at least 90% in a huge real-world study of 23 million people
- Vaccines cut the risk of developing severe COVID-19 by at least 90%, a study of 23 million people finds.
- COVID-19 vaccine protection lasted for at least five months in people aged 50 to 75, it found.
- It adds to a growing body of real-world evidence that vaccines hold up against severe COVID-19.
More stories we’re reading:
- 13 power-player lawyers advising life-sciences companies through the biotech feeding frenzy (Insider)
- A new panel says older adults shouldn’t take an aspirin each day to prevent heart attacks (Associated Press)
- Massachusetts’ National Guard will help test for COVID-19 in public schools as staffing shortages cause delays (Insider)
- The pandemic has heightened violence against healthcare workers (Kaiser Health News)